» Articles » PMID: 31379877

GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life

Overview
Journal Front Immunol
Date 2019 Aug 6
PMID 31379877
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Pharmacologically, glucocorticoids, which mediate their effects via the glucocorticoid receptor (GR), are a most effective therapy for inflammatory diseases despite the fact that chronic use causes side-effects and acquired GC resistance. The design of drugs with fewer side-effects and less potential for the development of resistance is therefore considered crucial for improved therapy. Dimerization of the GR is an integral step in glucocorticoid signaling and has been identified as a possible molecular site to target for drug development of anti-inflammatory drugs with an improved therapeutic index. Most of the current understanding regarding the role of GR dimerization in GC signaling derives for dimerization deficient mutants, although the role of ligands biased toward monomerization has also been described. Even though designing for loss of dimerization has mostly been applied for reduction of side-effect profile, designing for loss of dimerization may also be a fruitful strategy for the development of GC drugs with less potential to develop GC resistance. GC-induced resistance affects up to 30% of users and is due to a reduction in the GR functional pool. Several molecular mechanisms of GC-mediated reductions in GR pool have been described, one of which is the autologous down-regulation of GR density by the ubiquitin-proteasome-system (UPS). Loss of GR dimerization prevents autologous down-regulation of the receptor through modulation of interactions with components of the UPS and post-translational modifications (PTMs), such as phosphorylation, which prime the GR for degradation. Rational design of conformationally biased ligands that select for a monomeric GR conformation, which increases GC sensitivity through improving GR protein stability and increasing half-life, may be a productive avenue to explore. However, potential drawbacks to this approach should be considered as well as the advantages and disadvantages in chronic vs. acute treatment regimes.

Citing Articles

Aromatic Residue F443 Modulates the Dimer Interface and Activity of Glutathione Reductase.

Ho O, Hoang T, Lee C ACS Omega. 2025; 10(8):8709-8717.

PMID: 40060842 PMC: 11886668. DOI: 10.1021/acsomega.5c00192.


High-dose methylprednisolone mediates YAP/TAZ-TEAD in vocal fold fibroblasts with macrophages.

Nakamura R, Bing R, Gartling G, Garabedian M, Branski R Res Sq. 2024; .

PMID: 39070624 PMC: 11276011. DOI: 10.21203/rs.3.rs-4626638/v1.


Synephrine and Its Derivative Compound A: Common and Specific Biological Effects.

Dodonova S, Zhidkova E, Kryukov A, Valiev T, Kirsanov K, Kulikov E Int J Mol Sci. 2023; 24(24).

PMID: 38139366 PMC: 10744207. DOI: 10.3390/ijms242417537.


distillation of thermodynamic affinity from deep learning regulatory sequence models of protein-DNA binding.

Alexandari A, Horton C, Shrikumar A, Shah N, Li E, Weilert M bioRxiv. 2023; .

PMID: 37214836 PMC: 10197627. DOI: 10.1101/2023.05.11.540401.


Dose-Dependent Glucocorticoid Regulation of Transcription Factors in Vocal Fold Fibroblasts and Macrophages.

Nakamura R, Bing R, Gartling G, Garabedian M, Branski R Laryngoscope. 2023; 133(10):2704-2711.

PMID: 36752581 PMC: 10406972. DOI: 10.1002/lary.30594.


References
1.
van Tilborg M, Lefstin J, Kruiskamp M, Teuben J, Boelens R, Yamamoto K . Mutations in the glucocorticoid receptor DNA-binding domain mimic an allosteric effect of DNA. J Mol Biol. 2000; 301(4):947-58. DOI: 10.1006/jmbi.2000.4001. View

2.
Connell P, Ballinger C, Jiang J, Wu Y, Thompson L, Hohfeld J . The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol. 2001; 3(1):93-6. DOI: 10.1038/35050618. View

3.
Savory J, Prefontaine G, Lamprecht C, Liao M, Walther R, Lefebvre Y . Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces. Mol Cell Biol. 2001; 21(3):781-93. PMC: 86670. DOI: 10.1128/MCB.21.3.781-793.2001. View

4.
Wallace A, Cidlowski J . Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem. 2001; 276(46):42714-21. DOI: 10.1074/jbc.M106033200. View

5.
Sengupta S, Wasylyk B . Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. Genes Dev. 2001; 15(18):2367-80. PMC: 312780. DOI: 10.1101/gad.202201. View